Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.

Aneuploidy occurs early during tumorigenesis and may contribute to tumor formation. Tumor cells become aneuploid as a result of aberrant mitotic divisions, suggesting a tumorigenic contribution of the mechanisms in maintaining chromosomal number stability. We therefore speculated that the genes TTK, MAD2L1, BUB1, BUB1B and PTTG1 (Securin), jointly implicated in the regulation of mitotic checkpoint, might be associated with breast tumorigenesis. To test this hypothesis, this case-control study of 698 primary breast cancer patients and 1492 healthy controls examined single-nucleotide polymorphisms (SNPs) in these mitotic checkpoint genes to define their tumorigenic contribution. Because estrogen is known to promote breast cancer development via its mitogenic effect leading to malignant proliferation of breast epithelium and the mitotic checkpoint genes are involved in regulating mitosis, we were also interested in knowing whether any association between genotypes and breast cancer risk was modified by reproductive risk factors. Support for these hypotheses came from the observations that (i) two SNPs in TTK and PTTG1 were associated with breast cancer risk; (ii) haplotype and haplotype combination analyses in TTK, BUB1B and PTTG1 revealed a strong association with breast cancer risk; (iii) a trend to an increased risk of breast cancer was found in women harboring a greater number of putative high-risk genotypes/haplotypes of mitotic checkpoint genes and (iv) a significant interaction between high-risk genotypes/haplotypes and reproductive risk factors in determining breast cancer risk was defined. This study provides new support for the mutator role of mitotic checkpoint genes in breast cancer development, suggesting that breast cancer could be driven by genomic instability associated with variant mitotic checkpoint genes, the tumorigenic contribution of which could be enhanced as a result of increased mitosis due to estrogen exposure.

[1]  F. Kittrell,et al.  Hormone-Induced Chromosomal Instability in p53-Null Mammary Epithelium , 2004, Cancer Research.

[2]  S E Hodge,et al.  Logistic regression model for analyzing extended haplotype data , 1998, Genetic epidemiology.

[3]  J. Russo,et al.  Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.

[4]  C. W. Wu,et al.  A case-control study of breast cancer in Taiwan--a low-incidence area. , 1997, British Journal of Cancer.

[5]  Augusto Silva,et al.  Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis , 2002, Nature Genetics.

[6]  Chiun-Sheng Huang,et al.  Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset) , 1998, International journal of cancer.

[7]  J. Russo,et al.  Cellular basis of breast cancer susceptibility. , 1999, Oncology research.

[8]  H. Morgenstern,et al.  Epidemiologic Research: Principles and Quantitative Methods. , 1983 .

[9]  P. Sorger,et al.  Chromosome Missegregation and Apoptosis in Mice Lacking the Mitotic Checkpoint Protein Mad2 , 2000, Cell.

[10]  Geert J. P. L. Kops,et al.  On the road to cancer: aneuploidy and the mitotic checkpoint , 2005, Nature Reviews Cancer.

[11]  N. Rahman,et al.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B , 2004, Nature Genetics.

[12]  R. Cardiff,et al.  Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.

[14]  Z. Darżynkiewicz,et al.  BUBR1 deficiency results in abnormal megakaryopoiesis. , 2003, Blood.

[15]  L. Attardi.  The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. , 2005, Mutation research.

[16]  M. Pike,et al.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.

[17]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility , 2005, International journal of cancer.

[18]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[19]  P. Sorger,et al.  Generating chromosome instability through the simultaneous deletion of Mad2 and p53. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[21]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[22]  Chen-Yang Shen,et al.  TTK/hMps1 Participates in the Regulation of DNA Damage Checkpoint Response by Phosphorylating CHK2 on Threonine 68* , 2005, Journal of Biological Chemistry.

[23]  R. Lewontin,et al.  THE INTERACTION OF SELECTION AND LINKAGE. II. OPTIMUM MODELS. , 1964, Genetics.

[24]  Chen-Yang Shen,et al.  Association between N‐acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post‐menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence , 1999, International journal of cancer.

[25]  P. Sham,et al.  Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.

[26]  P. Jallepalli,et al.  Chromosome segregation and cancer: cutting through the mystery , 2001, Nature Reviews Cancer.

[27]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.

[28]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[29]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[30]  W. Pan,et al.  A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. , 2006, Journal of biomedical science.

[31]  S. Elledge,et al.  The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. , 2002, Cancer cell.

[32]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[33]  Viji M. Draviam,et al.  Chromosome segregation and genomic stability. , 2004, Current opinion in genetics & development.

[34]  X. Shu,et al.  Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. , 2003, Cancer research.

[35]  Francis Barany,et al.  Single nucleotide polymorphism seeking long term association with complex disease. , 2002, Nucleic acids research.

[36]  T. Sellers.  Genetic ancestry and molecular epidemiology. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  M J Khoury,et al.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.

[38]  G. Stancel,et al.  Estrogen receptor-mediated processes in normal and cancer cells. , 2000, Journal of the National Cancer Institute. Monographs.

[39]  P. Sham,et al.  Faster Haplotype Frequency Estimation Using Unrelated Subjects , 2002, Human Heredity.

[40]  C. Yue,et al.  Aberrant expression of cell‐cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability , 2002, Genes, chromosomes & cancer.

[41]  C. Yue,et al.  Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. , 2000, Cancer research.

[42]  Hongtao Yu,et al.  The spindle checkpoint, aneuploidy, and cancer , 2004, Oncogene.

[43]  A. Børresen-Dale,et al.  BUB1 infrequently mutated in human breast carcinomas , 2003, Human mutation.

[44]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotypic polymorphism of the mitosis‐regulating gene Aurora‐A/STK15/BTAK , 2005, International journal of cancer.

[45]  Yusuke Nakamura,et al.  A high-throughput SNP typing system for genome-wide association studies , 2001, Journal of Human Genetics.

[46]  Paolo Vineis,et al.  Individual susceptibility to carcinogens , 2004, Oncogene.